Federal Court Decisions

Decision Information

Decision Content


Date: 19980423


Docket: T-633-95

BETWEEN:

     MERCK FROSST CANADA INC.,

         -and-

     MERCK & CO., INC.,

     Applicants,

AND:

     THE MINISTER OF

     NATIONAL HEALTH AND WELFARE,

     -and-

     KYORIN PHARMACEUTICAL CO., LTD.

     -and-

     APOTEX INC.

     Respondents

     REASONS FOR ORDER

ROTHSTEIN J.:

[1]      On this application for costs on the basis of special circumstances, I have had regard to the various cases that have been pointed out by counsel. What these cases seem to indicate is that each decision is based on the facts of the case. Where from a factual analysis it is possible to deduce a principle, that would be helpful, but that is not the case here.

[2]      In the present case, Merck submits that the ultimate conclusion was that there was a finding of literal infringement. However, the fact that there may be literal infringement does not per se constitute special circumstances. There was evidence adduced and argument made by Apotex in the case. That Apotex's arguments were not accepted by the Court does not satisfy the requirement for special circumstances.

[3]      Although there was a suggestion of abuse of the process, the circumstances do not support such a finding.

[4]      On the facts of this case there are no special circumstances justifying an award of costs. There will be no award of costs.

     Marshall Rothstein

    

     J U D G E

OTTAWA, ONTARIO

APRIL 23, 1998

 You are being directed to the most recent version of the statute which may not be the version considered at the time of the judgment.